Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements


Download results of this page


Refine by:

Country

Australia (1)
Austria (6)
Belgium (21)
Burkina Faso (1)
Czech Republic (3)
Denmark (9)
Finland (9)
France (19)
Gabon (1)
Germany (25)
Greece (1)
Hungary (1)
Ireland (3)
Israel (1)
Italy (17)
Luxembourg (6)
Netherlands (27)
Norway (1)
Poland (1)
Portugal (1)
Senegal (1)
Slovenia (3)
Spain (13)
Sweden (16)
Switzerland (16)
United Kingdom (29)
United States (11)

Language

English (71)

Advanced search

Results 1 - 10 of 71
Results/page:
12 3 4 5 6 7 8 > 
Development of Robust and Innovative Vaccine Effectiveness
ID: 777363
Start date: 2017-07-01, End date: 2022-06-30
Influenza is a major public health problem. In a conservative estimate, influenza infects annually 60 of the 500 million inhabitants of the EU. Vaccines are the cornerstone for preventing influenza and its consequences. Current influenza vaccines have a moderate variable...
Programme: H2020-EU.3.1.7.12.
Record Number: 211596
Last updated on: 2017-08-17
Periodic Reporting for period 1 - EBOVAC2 (Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen: Phase II)
The Ebola virus disease (EVD) is an acute illness with a very high case-fatality rate caused by a highly lethal viral pathogen of the Filoviridae family. Ebola virus first appeared in 1976 in two simultaneous outbreaks, one in Nzara, Sudan, and the other in Yambuku, Democratic...
Programme: H2020-EU.3.1.7.13.
Record Number: 230029
Last updated on: 2018-05-22
Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management
ID: 777365
Start date: 2017-09-01, End date: 2022-08-31
Drug safety assessment is a knowledge-intensive process that demands advancement in data handling methods and tools for facilitating data sharing, mining, analysis and predictive modelling. This need is not restricted to any specific type of data and real advancement...
Programme: H2020-EU.3.1.7.13.
Record Number: 212141
Last updated on: 2017-12-06
PERtussIS COrrelates of Protection Europe
ID: 115910
Start date: 2016-03-01, End date: 2021-02-28
Pertussis vaccines have been very successful in reducing the global burden of pertussis-related disease. However, in the last decade there has been a rise in pertussis incidence, particularly in vaccinated adolescents and adults in industrialized countries. The increased...
Programme: H2020-EU.3.1.7.12.
Record Number: 209454
Last updated on: 2017-03-27
Vaccine safety and immunogenicity signatures of human responses to VSV-ZEBOV
ID: 115842
Start date: 2015-03-01, End date: 2018-02-28
The proposal, VSV-EBOVAC, directly addresses the topic 1 of the IMI2 call on Ebola by supporting the clinical development of a highly promising new Ebola vaccine candidate, the vesicular stomatitis virus (VSV)‐ vectored Zaire Ebola vaccine (VSV-ZEBOV). In non-human primates...
Programme: H2020-EU.3.1.7.13.
Record Number: 209443
Last updated on: 2017-06-10
Periodic Reporting for period 1 - PERISCOPE (PERtussIS COrrelates of Protection Europe)
A new generation of Pertussis vaccines or improved vaccination schedules is needed to meet the persistent burden of Pertussis infection in developing countries and to reduce the risk of contracting Pertussis disease in industrialised countries, which recent observations...
Programme: H2020-EU.3.1.7.12.
Record Number: 228358
Last updated on: 2018-05-10
Periodic Reporting for period 1 - EbolaMoDRAD (Ebola Virus: Modern Approaches for developing  bedside Rapid Diagnostics)
The overall aim of EbolaMoDRAD has been to develop and deliver rapid and bedside diagnostic tool(s) that will significantly increase our capacity to handle Ebola Virus Disease (EVD) in West Africa in the 2014-2015 and future outbreaks. This will/has been done via a...
Programme: H2020-EU.3.1.7.13.
Record Number: 228373
Last updated on: 2018-05-10
Periodic Reporting for period 1 - ADAPT-SMART (Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes)
Progress in life sciences and related technologies offers the potential to bring a wide range of beneficial new therapies to patients over the coming years. There will be more personalised or stratified medicines, combinations, borderline products, and advanced therapies that...
Programme: H2020-EU.3.1.7.13.
Record Number: 228436
Last updated on: 2018-05-10
Periodic Reporting for period 1 - FILODIAG (Ultra-Fast Molecular Filovirus Diagnostics)
The aim of this project is to provide an ultra-fast and accurate molecular diagnostic platform that can perform a molecular test on the Ebola virus within 10-15 minutes. Patients, suspected of EVD, due to fever and/or other clinical signs, could be rapidly and accurately...
Programme: H2020-EU.3.1.7.13.
Record Number: 228432
Last updated on: 2018-05-10
Manufacturing and Development for Rapid Access Ebola Vaccine (EBOMAN)
ID: 115850
Start date: 2014-12-01, End date: 2017-11-30
This topic response (Topic 2: Manufacturing Capability) forms part of an integrated proposal to address the urgent unmet needs of accelerating the development of an Ebola vaccine. To help facilitate this main goal additional activities will be performed; the generation of...
Programme: H2020-EU.3.1.7.13.
Record Number: 209444
Last updated on: 2017-03-27
12 3 4 5 6 7 8 > 
List retrieved on: 2018-05-27
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top